Related references
Note: Only part of the references are listed.A Syrian Golden Hamster Model Recapitulating Ebola Hemorrhagic Fever
Hideki Ebihara et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Airway Delivery of an Adenovirus-Based Ebola Virus Vaccine Bypasses Existing Immunity to Homologous Adenovirus in Nonhuman Primates
Jason S. Richardson et al.
JOURNAL OF VIROLOGY (2013)
Induction of Broad Cytotoxic T Cells by Protective DNA Vaccination Against Marburg and Ebola
Devon J. Shedlock et al.
MOLECULAR THERAPY (2013)
Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates
Andrea Marzi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Animal models for highly pathogenic emerging viruses
David Safronetz et al.
CURRENT OPINION IN VIROLOGY (2013)
Antibody Quality and Protection from Lethal Ebola Virus Challenge in Nonhuman Primates Immunized with Rabies Virus Based Bivalent Vaccine
Joseph E. Blaney et al.
PLOS PATHOGENS (2013)
Current ebola vaccines
Thomas Hoenen et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
A Single Sublingual Dose of an Adenovirus-Based Vaccine Protects against Lethal Ebola Challenge in Mice and Guinea Pigs
Jin Huk Choi et al.
MOLECULAR PHARMACEUTICS (2012)
Ad35 and Ad26 Vaccine Vectors Induce Potent and Cross-Reactive Antibody and T-Cell Responses to Multiple Filovirus Species
Roland Zahn et al.
PLOS ONE (2012)
Immune Parameters Correlate with Protection Against Ebola Virus Infection in Rodents and Nonhuman Primates
Gary Wong et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Further characterization of the immune response in mice to inactivated and live rabies vaccines expressing Ebola virus glycoprotein
Amy B. Papaneri et al.
VACCINE (2012)
Human Papillomavirus Vaccines - Immune Responses
Margaret Stanley et al.
VACCINE (2012)
A replication-deficient rabies virus vaccine expressing Ebola virus glycoprotein is highly attenuated for neurovirulence
Amy B. Papaneri et al.
VIROLOGY (2012)
A multiagent filovirus DNA vaccine delivered by intramuscular electroporation completely protects mice from ebola and Marburg virus challenge
Rebecca J. Grant-Klein et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Recombinant Vesicular Stomatitis Virus Vaccine Vectors Expressing Filovirus Glycoproteins Lack Neurovirulence in Nonhuman Primates
Chad E. Mire et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Protective Efficacy of a Bivalent Recombinant Vesicular Stomatitis Virus Vaccine in the Syrian Hamster Model of Lethal Ebola Virus Infection
Yoshimi Tsuda et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Filovirus Infection of STAT-1 Knockout Mice
JoLynne Raymond et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Kunjin Virus Replicon-Based Vaccines Expressing Ebola Virus Glycoprotein GP Protect the Guinea Pig Against Lethal Ebola Virus Infection
O. Reynard et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Impact of Systemic or Mucosal Immunity to Adenovirus on Ad-Based Ebola Virus Vaccine Efficacy in Guinea Pigs
Jason S. Richardson et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Advances in Virus-Like Particle Vaccines for Filoviruses
Kelly L. Warfield et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Vesicular Stomatitis Virus-Based Ebola Vaccines With Improved Cross-Protective Efficacy
Andrea Marzi et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Recombinant Adenovirus Serotype 26 (Ad26) and Ad35 Vaccine Vectors Bypass Immunity to Ad5 and Protect Nonhuman Primates against Ebolavirus Challenge
Thomas W. Geisbert et al.
JOURNAL OF VIROLOGY (2011)
Inactivated or Live-Attenuated Bivalent Vaccines That Confer Protection against Rabies and Ebola Viruses
Joseph E. Blaney et al.
JOURNAL OF VIROLOGY (2011)
CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates
Nancy J. Sullivan et al.
NATURE MEDICINE (2011)
A Replicating Cytomegalovirus-Based Vaccine Encoding a Single Ebola Virus Nucleoprotein CTL Epitope Confers Protection against Ebola Virus
Yoshimi Tsuda et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Protection of Nonhuman Primates against Two Species of Ebola Virus Infection with a Single Complex Adenovirus Vector
William D. Pratt et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults
J. E. Ledgerwood et al.
VACCINE (2010)
Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response
Joshua M. DiNapoli et al.
VACCINE (2010)
International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: Correlates of high Ad5 titers and implications for potential HIV vaccine trials
T. Christopher Mast et al.
VACCINE (2010)
Mucosal parainfluenza virus-vectored vaccine against Ebola virus replicates in the respiratory tract of vector-immune monkeys and is immunogenic
Alexander A. Bukreyev et al.
VIROLOGY (2010)
Demonstration of Cross-Protective Vaccine Immunity against an Emerging Pathogenic Ebolavirus Species
Lisa E. Hensley et al.
PLOS PATHOGENS (2010)
Disease modeling for Ebola and Marburg viruses
Dennis Bente et al.
DISEASE MODELS & MECHANISMS (2009)
Replication-Deficient Ebolavirus as a Vaccine Candidate
Peter Halfmann et al.
JOURNAL OF VIROLOGY (2009)
Single-Injection Vaccine Protects Nonhuman Primates against Infection with Marburg Virus and Three Species of Ebola Virus
Thomas W. Geisbert et al.
JOURNAL OF VIROLOGY (2009)
Enhanced Protection against Ebola Virus Mediated by an Improved Adenovirus-Based Vaccine
Jason S. Richardson et al.
PLOS ONE (2009)
Mucosal Immunization of Cynomolgus Macaques with the VSVΔG/ZEBOVGP Vaccine Stimulates Strong Ebola GP-Specific Immune Responses
Xiangguo Qiu et al.
PLOS ONE (2009)
Chimeric human parainfluenza virus bearing the Ebola virus glycoprotein as the sole surface protein is immunogenic and highly protective against Ebola virus challenge
Alexander Bukreyev et al.
VIROLOGY (2009)
Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections
Dana L. Swenson et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Current progress of DNA vaccine studies in humans
Shan Lu et al.
EXPERT REVIEW OF VACCINES (2008)
Nasal Delivery of an Adenovirus-Based Vaccine Bypasses Pre-Existing Immunity to the Vaccine Carrier and Improves the Immune Response in Mice
Maria A. Croyle et al.
PLOS ONE (2008)
Generation of biologically contained Ebola viruses
Peter Halfmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses
Thomas W. Geisbert et al.
VACCINE (2008)
Filovirus-like particles produced in insect cells: Immunogenicity and protection in rodents
Kelly L. Warfield et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge
Kelly L. Warfield et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Assessment of a vesicular stomatitis virus-based vaccine by use of the mouse model of Ebola virus hemorrhagic fever
Steven M. Jones et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Successful topical respiratory tract immunization of primates against ebola virus
Alexander Bukreyev et al.
JOURNAL OF VIROLOGY (2007)
Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice
John S. Lee et al.
VACCINE (2006)
A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial
Julie E. Martin et al.
CLINICAL AND VACCINE IMMUNOLOGY (2006)
Generation of an adenoviral vaccine vector based on simian adenovirus 21
Soumitra Roy et al.
JOURNAL OF GENERAL VIROLOGY (2006)
Chimpanzee adenovirus vaccine protects against Zaire Ebola virus
GP Kobinger et al.
VIROLOGY (2006)
A single intranasal inoculation with a paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challenge
A Bukreyev et al.
JOURNAL OF VIROLOGY (2006)
Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection
KL Warfield et al.
JOURNAL OF IMMUNOLOGY (2005)
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses
SM Jones et al.
NATURE MEDICINE (2005)
Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections
DL Swenson et al.
VACCINE (2005)
Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses
M Garbutt et al.
JOURNAL OF VIROLOGY (2004)
Ebola virus-like particles protect from lethal Ebola virus infection
KL Warfield et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus
J Riemenschneider et al.
VACCINE (2003)
Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates
NJ Sullivan et al.
NATURE (2003)
Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 Gag have greatly reduced pathogenicity but are highly immunogenic
JP McGettigan et al.
JOURNAL OF VIROLOGY (2003)
An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants
NF Rose et al.
CELL (2001)
Vaccine potential of Ebola virus VP24, VP30, VP36, and VP40 proteins
JA Wilson et al.
VIROLOGY (2001)
Protection from Ebola virus mediated by cytotoxic T lymphocytes specific for the viral nucleoprotein
JA Wilson et al.
JOURNAL OF VIROLOGY (2001)
Development of a preventive vaccine for Ebola virus infection in primates
NJ Sullivan et al.
NATURE (2000)
Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus
P Pushko et al.
VACCINE (2000)
Human parainfluenza virus type 3 (PIV3) expressing the hemagglutinin protein of measles virus provides a potential method for immunization against measles virus and PIV3 in early infancy
AP Durbin et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
